condition	mean	min	max
0.1 mm CuSO4,WT	0.0	0.0	0.0
1-napp-1,WT	0.0	0.0	0.0
1n,MATa,NaCl,WT	0.0	0.0	0.0
1n,MATa,WT	0.0	0.0	0.0
1n,MATa,unstressed,WT	0.0	0.0	0.0
1n,MATalpha,WT	0.0	0.0	0.0
1n,WT	0.0	0.0	0.0
1n,addition of 1nm-pp1,WT	3.3835	0.0	6.767
200 mm hu,WT	0.0	0.0	0.0
39C,YPD,WT	0.0	0.0	0.0
SC-URA + 20g/l glucose,WT	0.0	0.0	0.0
SDC,WT	0.0	0.0	0.0
WT	1.5242466666666667	0.0	361.19
YEP + lactic acid + 2% gal,WT	0.0	0.0	0.0
YEP + lactic acid,WT	0.0	0.0	0.0
YP + 3% glycerol,WT	0.0	0.0	0.0
YPD,WT	0.0	0.0	0.0
YPDA,WT	0.0	0.0	0.0
YPEG,WT	0.0	0.0	0.0
azetidine,YPD,WT	0.0	0.0	0.0
cmk treatment,WT	0.0	0.0	0.0
dmso,WT	0.0	0.0	0.0
elutriation + 1nm-pp1,WT	16.61405	0.0	33.2281
fluco,YPD,WT	0.0	0.0	0.0
gal, 2h + hu 200 mm,WT	0.0	0.0	0.0
gal, 4h + hu 200 mm,WT	0.0	0.0	0.0
gal,WT	0.0	0.0	0.0
glucose,WT	0.0	0.0	0.0
heatshock,WT	25.8796	0.0	93.4359
hu, 1h,WT	0.0	0.0	0.0
hu, 2h,WT	0.0	0.0	0.0
hu, 4h,WT	0.0	0.0	0.0
log,WT	0.8313826086956522	0.0	19.1218
med 35 6aa,WT	0.0	0.0	0.0
med 35 ammonium,WT	0.0	0.0	0.0
med 35 complete,WT	0.0	0.0	0.0
menadione,YPD,WT	0.0	0.0	0.0
mid-log,WT	0.0	0.0	0.0
mid-log,untreated,WT	0.0	0.0	0.0
mid-log,vts1 OE,WT	0.0	0.0	0.0
min med, chemostat,WT	0.0	0.0	0.0
rap,YPD,WT	0.0	0.0	0.0
ribo depletion,WT	0.0	0.0	0.0
salt,YPD,WT	0.0	0.0	0.0
stat,WT	0.0	0.0	0.0
syn dext,WT	0.0	0.0	0.0
synthetic complete med,20C,WT	0.0	0.0	0.0
synthetic defined med,WT	0.0	0.0	0.0
treated,WT	0.0	0.0	0.0
tunicamycin,YPD,WT	0.0	0.0	0.0
untreated,WT	2.4090964285714285	0.0	16.9364
ypsorbitol (2.02%),YPD,WT	0.0	0.0	0.0